Union Bank Board Approves Up to Rs 8000 Crore Fundraise via Equity and Debt Wall Street Holds Steady as Healthcare Rally Offsets Industrials Drag 99 of CEOs Expect AIDriven Layoffs Within Two Years Mercer Study Shows Fed Rate Hike Expectations Surge After Inflation Data Market Ponders December Move SpaceX IPO Hype Raises Questions on Valuation Logic Uber Technologies Increases Stake in Delivery Hero SE Bloomberg Reports ENR Q1 2026 Earnings Stellar EPS Beat Propels Shares Higher VLYPO Q1 2026 Earnings Preferred EPS Beats Estimates as Bank Navigates Steady Earnings Environment Trinity Capital Inc TRIN Q1 2026 Earnings EPS Beats Estimates by 116 RingCentral Q1 2026 Earnings EPS Beats Estimates as Stock Rises 313 Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline HSLV Q1 2026 Earnings Massive EPS Surprise Despite No Reported Revenue Miller Industries MLR Edges Higher as Shares Hold Steady Near Key Resistance Levels Stardust Power SDST Gains 5 as Shares Test Key Resistance Levels Monopar Therapeutics MNPR Surges 3 as Biotech Momentum Builds Tests Key Resistance i80 Gold Corp IAUX Slips 097 as Traders Eye 145 Support Zone Corporacion America Airports CAAP Faces Resistance at 2621 Amid Slight Pullback Should a 63YearOld With 14 Million Convert to a Roth While Expecting to Live to 100 RNGR Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Details Remain Unclear Cohu Inc COHU Rallies Over 5 as Semiconductor Equipment Demand Trends Improve Community Healthcare Trust CHCT Q1 2026 Earnings Massive EPS Beat Masks Continued Market Caution Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares 7 PTC Q1 2026 Earnings Strong EPS Surprise Drives Positive Market Response CubeSmart CUBE Q1 2026 Earnings EPS Beats Estimates Amid Stable Operations Evergy Q1 2026 Earnings EPS Beats Estimates with 458 Surprise Shift4 Payments FOUR Q1 2026 Earnings A Narrow EPS Miss During Transition Quarter Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline